Showing results (51-60 of 55) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
BMJ Open|October 6, 2018
Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort studyLina Davies Forsman, Katarina Niward, Yi Hu, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2023
Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilutionGabrielle Fröberg, Florian P Maurer, Erja Chryssanthou, et al.The Journal of Antimicrobial Chemotherapy|March 9, 2022
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanidAnna Bateson, Julio Ortiz Canseco, Timothy D McHugh, et al.Antimicrobial Agents and Chemotherapy|October 16, 2013
Optimization of pyrrolamides as mycobacterial GyrB ATPase inhibitors: structure-activity relationship and in vivo efficacy in a mouse model of tuberculosisShahul Hameed P, Suresh Solapure, Kakoli Mukherjee, et al.Journal of Medicinal Chemistry|May 10, 2014
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosisShahul Hameed P, Vikas Patil, Suresh Solapure, et al.Pageof 6